These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27958633)

  • 21. [First trimester diagnosis of chromosomal defects].
    Nicolaides KH; Wegrzyn P
    Ginekol Pol; 2005 Jan; 76(1):1-8. PubMed ID: 15844559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasal bone in first-trimester screening for trisomy 21.
    Cicero S; Avgidou K; Rembouskos G; Kagan KO; Nicolaides KH
    Am J Obstet Gynecol; 2006 Jul; 195(1):109-14. PubMed ID: 16813749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost effectiveness, the economic considerations of prenatal screening strategies for trisomy 21 in the Czech Republic.
    Dhaifalah I; Májek O
    Ceska Gynekol; 2012 Feb; 77(1):39-51. PubMed ID: 22536640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
    Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
    Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
    Soergel P; Pruggmayer M; Schwerdtfeger R; Muhlhaus K; Scharf A
    Fetal Diagn Ther; 2006; 21(3):264-8. PubMed ID: 16601335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic methods for fetal malformations in the first half of pregnancy].
    Sieroszewski P; Suzin J; Baś-Budecka E
    Ginekol Pol; 2003 Oct; 74(10):1276-83. PubMed ID: 14669430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasal bone in screening for Trisomy 18 and 13 at 11-13 + 6 weeks of gestation - own experiences.
    Czuba B; Maczka M; Cnota W; Wloch A; Jagielska A; Niesluchowska-Hoxha A; Borowski D
    Ginekol Pol; 2020; 91(5):256-261. PubMed ID: 32495931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.
    Nicolaides KH
    Am J Obstet Gynecol; 2004 Jul; 191(1):45-67. PubMed ID: 15295343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective validation of first-trimester combined screening for trisomy 21.
    Kagan KO; Etchegaray A; Zhou Y; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Jul; 34(1):14-8. PubMed ID: 19526452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies.
    Zoppi MA; Ibba RM; Axiana C; Floris M; Manca F; Monni G
    Prenat Diagn; 2003 Jun; 23(6):496-500. PubMed ID: 12813765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fetal hepatic artery flow assessment in prenatal diagnostics--a review of the literature].
    Lipa M; Samaha RB; Borowski D; Wielgoś M; Wegrzyn P
    Ginekol Pol; 2014 Jul; 85(7):532-5. PubMed ID: 25118506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Hoopmann M; Abele H; Alkier R; Lüthgens K
    Ultrasound Obstet Gynecol; 2012 Nov; 40(5):530-5. PubMed ID: 22611005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women.
    Wøjdemann KR; Shalmi AC; Christiansen M; Larsen SO; Sundberg K; Brocks V; Bang J; Nørgaard-Pedersen B; Tabor A
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):227-33. PubMed ID: 15736185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal nasal bone assessment in first trimester down syndrome screening.
    Has R; Kalelioglu I; Yuksel A; Ibrahimoglu L; Ermis H; Yildirim A
    Fetal Diagn Ther; 2008; 24(1):61-6. PubMed ID: 18504384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of human chorionic gonadotropin (beta hCG) levels and sonographic assesement of fetal nuchal translucency (NT) in singleton pregnancies between 11 and 14 weeks of gestation--Polish multi-centre research].
    Borowski D; Czuba B; Cnota W; Hincz P; Czekierdowski A; Gajewska J; Jaczyńska R; Ceran A; Włoch A; Wyrwas D; Wiełgoś M; Szymusik I; Szaflik K; Sodowski K
    Ginekol Pol; 2007 May; 78(5):384-7. PubMed ID: 17867331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-trimester fetal nasal bone length in an ethnic Chinese population.
    Sahota DS; Leung TY; Chan LW; Law LW; Fung TY; Chan OK; Lau TK
    Ultrasound Obstet Gynecol; 2009 Jul; 34(1):33-7. PubMed ID: 19424993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13.
    Santorum M; Wright D; Syngelaki A; Karagioti N; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):714-720. PubMed ID: 27549925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of combined detailed first-trimester ultrasound-biochemical analysis for screening fetal aneuploidy in the era of non-invasive prenatal testing.
    Ye C; Duan H; Liu M; Liu J; Xiang J; Yin Y; Zhou Q; Yang D; Yan R; Li R
    Arch Gynecol Obstet; 2024 Aug; 310(2):843-853. PubMed ID: 37938359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.